NanoViricides (NNVC) Says Topical Drug Candidates for Treatment of Shingles Demonstrated Excellent Inhibition of Causative Virus

June 6, 2017 5:31 PM EDT Send to a Friend
NanoViricides, Inc., (NYSE: NNVC) (the "Company"), a pioneer in developing anti-viral nanomedicine drugs, reports that its topical drug candidates in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login